Brought to you by 
Altana, GPC enter drug discovery agreement
Nov 2001
Executive Summary
In a three-part transaction, Altana has made a made a $30.8mm (Euro34.2mm) equity investment in GPC Biotech (at about a 70% premium) and signed two deals with GPC through its Byk Gulden division.
Deal Industry
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
- Genomics-Proteomics
-
Drug Discovery Tools
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- R+D and Marketing-Licensing
- Includes Royalty or Profit Split Information
- Includes Contract
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Altana, GPC enter drug discovery agreement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice